<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="case-report"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>ejm</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Ege Tıp Dergisi</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1016-9113</issn>
                                        <issn pub-type="epub">2147-6500</issn>
                                                                                            <publisher>
                    <publisher-name>Ege University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.19161/etd.1736794</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Neurology and Neuromuscular Diseases</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Nöroloji ve Nöromüsküler Hastalıklar</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <trans-title-group xml:lang="tr">
                                    <trans-title>Önceden CIDP tanısı almış bir hastada ortaya çıkan miyastenia gravis: Örtüşen otoimmün hastalıklarda klinik zorluklar</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>A case of myasthenia gravis emerging after prior diagnosis of CIDP: Clinical challenges in overlapping autoimmune disorders</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-3994-0019</contrib-id>
                                                                <name>
                                    <surname>Aykaç</surname>
                                    <given-names>Şeyma</given-names>
                                </name>
                                                                    <aff>EGE ÜNİVERSİTESİ, EGE TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0009-0006-1995-210X</contrib-id>
                                                                <name>
                                    <surname>Arı</surname>
                                    <given-names>Abdullah</given-names>
                                </name>
                                                                    <aff>EGE ÜNİVERSİTESİ, EGE TIP FAKÜLTESİ, EGE TIP PR.</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-0565-4922</contrib-id>
                                                                <name>
                                    <surname>Dere</surname>
                                    <given-names>Birgül</given-names>
                                </name>
                                                                    <aff>EGE ÜNİVERSİTESİ, EGE TIP FAKÜLTESİ, EGE TIP PR.</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-8283-9680</contrib-id>
                                                                <name>
                                    <surname>Seçil</surname>
                                    <given-names>Yaprak</given-names>
                                </name>
                                                                    <aff>İZMİR KATİP ÇELEBİ ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-4590-6423</contrib-id>
                                                                <name>
                                    <surname>Yüceyar</surname>
                                    <given-names>Ayşe Nur</given-names>
                                </name>
                                                                    <aff>EGE ÜNİVERSİTESİ, EGE TIP FAKÜLTESİ, EGE TIP PR.</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20251208">
                    <day>12</day>
                    <month>08</month>
                    <year>2025</year>
                </pub-date>
                                        <volume>64</volume>
                                        <issue>4</issue>
                                        <fpage>716</fpage>
                                        <lpage>720</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20250711">
                        <day>07</day>
                        <month>11</month>
                        <year>2025</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20250930">
                        <day>09</day>
                        <month>30</month>
                        <year>2025</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1962, Ege Journal of Medicine</copyright-statement>
                    <copyright-year>1962</copyright-year>
                    <copyright-holder>Ege Journal of Medicine</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="tr">
                            <p>Kronik inflamatuar demiyelinizan polinöropati (CIDP) ve miyastenia gravis (MG), nadiren birlikte görülen iki farklı otoimmün nöromüsküler hastalıktır. Stabil CIDP’si olan 52 yaşındaki erkek hasta, ilerleyici alt ekstremite ve fasyal güçsüzlükle başvurdu. Elektrofizyolojik incelemelerde nöromüsküler kavşak disfonksiyonu saptandı ve asetilkolin reseptör antikorlarının yüksek olması MG tanısını doğruladı. Piridostigmin, intravenöz immünglobulin ve rituksimab tedavisiyle klinik stabilite sağlandı. Bu olgu, CIDP’li hastalarda yeni veya atipik semptomlarda eşlik eden otoimmün hastalıkların düşünülmesinin önemini vurgulamaktadır. Elektrofizyolojik ve serolojik testlerle erken tanı, eşzamanlı CIDP ve MG yönetiminde etkilidir.</p></trans-abstract>
                                                                                                                                    <abstract><p>Chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) are distinct autoimmune neuromuscular disorders that rarely coexist. We present a 52-year-old man with stable CIDP who developed progressive lower limb weakness and facial involvement. Electrophysiological studies revealed neuromuscular junction dysfunction, and elevated acetylcholine receptor antibodies confirmed MG. Treatment with pyridostigmine, intravenous immunoglobulin, and rituximab resulted in clinical stabilization. This case shows the importance of considering overlapping autoimmune disorders in CIDP patients with new or atypical symptoms. Early recognition using electrophysiological and serological tests is important for accurate diagnosis and effective management of coexisting CIDP and MG.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>CIDP</kwd>
                                                    <kwd>  myasthenia gravis</kwd>
                                                    <kwd>  diagnostic challenge</kwd>
                                                    <kwd>  immunosuppression</kwd>
                                                    <kwd>  rituximab.</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="tr">
                                                    <kwd>CIDP</kwd>
                                                    <kwd>  myasthenia gravis</kwd>
                                                    <kwd> </kwd>
                                                    <kwd>  tanı güçlüğü</kwd>
                                                    <kwd>  immunsupresyon</kwd>
                                                    <kwd>  rituximab</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Mathey EK, Park SB, Hughes RA, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015;86:973- 985. doi:10.1136/jnnp-2014.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8:475-490.doi:10.1016/S1474-4422(09)70063-8.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia	gravis:	Executive	summary. Neurology.	2016;87:419-425. doi:10.1212/WNL.0000000000002790.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Weinreb H, Klein J, Kupersmith M. Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy. N Y State J Med 1986;86:439 – 42.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Inatsu A, Ohi T, Shioya K, Matsukura S. A case of myasthenia gravis occurring in the period of remission of chronic inflammatory demyelinating polyradiculoneuropathy. Rinsho Shinkeigaku 1992;32: 878 – 879.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Patwa HS, Fecko JF, Goldstein JM. Concurrent myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 1996;19:1059-1060.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Sempere AP, Claveria LE, Cru4Martine4 A, et al. Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 19964;3:397398.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Kimura K, Nezu A, Kimura S, et al. A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy. Neuropediatrics. 1998;29:108-112. doi:10.1055/s-2007-973544.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Tam DA, Chalmers A. Chronic inflammatory demyelinating polyneuropathy and myasthenia gravis. J Child Neurol. 1999;14:478-479. doi:10.1177/088307389901400715.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">1Shankar V, Sayeed ZA. Myasthenia gravis with chronic inflammatory demyelinating polyneuropathy - A case report. Neurol India. 1999;47:78-79.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">Magot A, Wiertlewski S, Boutoleau C, et al. Ptosis et troubles de la mastication révélateurs d&#039;une association myasthénie et polyradiculonévrite chronique [Ptosis and mastication disorders revealing concurrent myasthenia gravis and chronic polyradiculoneuritis]. Rev Neurol (Paris). 2002;158:741- 743.</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">Mori M, Kuwabara S, Nemoto Y, et al. Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection. J Neurol Sci. 2006;240:103-106. doi:10.1016/j.jns.2005.08.013.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">Quan W, Xia J, Tong Q, et al. Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy in the same patient - a case report. Int J Neurosci. 2018;128:570-572. doi:10.1080/00207454.2017.1398160.</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">Sumit D, Jyoti BT, Musharraf H, et al. Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy in the Same Patient: A Clinical Rarity. International Journal of Neurology and Neurosurgery. 2018;10:277-279. doi: http://dx.doi.org/10.21088/i5nns.0975.0223.10318.23.</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">Jiang N, Kazamel M. Concomitant Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Myasthenia Gravis-A Two-Case Report. Acta Scientific Neurology. 2020;3:117-120.</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">Martić V, Fejzić E, Marić N. Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Patient with Recurrent Thymoma. SrpSki medicinSki čaSopiS LekarSke komore.2023;4:188-192.</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">Hickman SJ, Allen JA, Baisre A, et al. Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Neuroophthalmology. 2013;37:146-156. doi:10.3109/01658107.2013.809459.</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">Grüter T, Motte J, Fisse AL, et al. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2020;27:2595-2603. doi:10.1111/ene.14476.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">Mausberg AK, Dorok M, Stettner M, Muller M, Hartung HP, Dehmel T, Warnke C, Meyer Zu Horste G, Kieseier BC. Recovery of the T-cell repertoire in CIDP by IV immunoglobulins. Neurology. 2013;80:296–303. doi: 10.1212/WNL.0b013e31827debad].</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta. 2015;1852:658–666. doi: 10.1016/j.bbadis.2014.06.013.].</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">Dalakas MC. Future perspectives in target-specific immunotherapies of myasthenia gravis. Ther Adv Neurol Disord. 2015;8:316–327. doi: 10.1177/1756285615605700.].</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">Krampfl K, Mohammadi B, Buchwald B, et al. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels. Muscle Nerve. 2003;27:435-441. doi:10.1002/mus.10349.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2: 389-400</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">Sawhney S, Asranna A, Sureshbabu S, et al. Malignant thymoma and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 2021;63:E10-E13. doi:10.1002/mus.27132.</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">Mathew T, Thomas K, K John S, et al. Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab; the Experience from a Neuroimmunology Clinic in a Developing Country. J Cent Nerv Syst Dis. 2021;13:11795735211016080. doi:10.1177/11795735211016080</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">Piehl F, Eriksson-Dufva A, Budzianowska A, et al. Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial. JAMA Neurol. 2022;79(11):1105-1112. doi:10.1001/jamaneurol.2022.2887</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">Roux T, Debs R, Maisonobe T, et al. Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases. J Peripher Nerv Syst. 2018;23:235-240. d Du Y, Yan</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">Du Y, Yan Q, Li C, et al. Efficacy and safety of combined low-dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy. Ann Clin Transl Neurol. 2025;12:180-191. doi:10.1002/acn3.52270oi:10.1111/jns.12287.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
